Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,cash,totalCurrentLiabilities,shortLongTermDebt,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,repurchaseOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,currency,esgPopulated,tradeable,exchangeDataDelayedBy,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,exchange,marketState,market,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,GBNH,-10361640,16089100,,,-7836166,-1110172,-7626554,6981136,1966837,-6810436,-6810436,,-1027912,,,,0,11313175,18123611,9346338,-1025730,,-7836166,-7626554,5628566,3548936,58274947,-1025424,4947597,56139351,63254170,-67828530,155239,3707650,5933799,20784539,1531808,28235972,18567163,10736212,14762928,7837391,-532187.0,-3828408.0,-1352666.0,-2797561.0,-746477.0,23059.0,-12872943.0,-6246974.0,1590167.0,2182.0,-28150.0,-1467954.0,1096227.0,,-2217376,en-US,US,EQUITY,True,Delayed Quote,USD,False,False,0,8.3524,4.1762,2.0 - 16.255,-5.9025993,-0.36312518,2.0,16.255,1620849600,1636405200,1637010000,0.023183038,10.24 - 10.3524,10.35,10.35,10.44,10,11,finmb_558073021,NasdaqCM,Greenbrook TMS Inc.,USD,5300,2966,11.173833,-0.82143307,-0.07351399,12.130369,-1.7779694,-0.14657174,166560800,15,America/New_York,EDT,-14400000,2,NCM,POST,us_market,Greenbrook TMS Inc.,10.3524,1630526399,0.0023994446,10.37,10.3524,10.24,1200,0.97,,,16.25,2.0,11.17,12.13,5.3k,2.97k,16.09M,,7M,33.60%,18.62%,11.63k,4.8,,0.08%,6.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-77.01%,-47.69%,-23.27%,-411.21%,43.02M,3.19,-0.90%,11.59M,-21.05M,-33.13M,,,5.93M,0.43,44.18M,,0.89,,-11.64M,-2.06M,Value,M4W 3P4,Healthcare,366,"Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.",Toronto,416 621 4642,ON,1609372800,Canada,http://www.greenbrooktms.com,86400,890 Yonge Street,Medical Care Facilities,7th Floor
t-1,GBNH,-6175747,16089100,,,-8759528,-392560,-8391630,7598185,2312083,-6992092,-6992092,,-745579,,,,0,9913552,16905644,7601469,-1767436,,-8759528,-8391630,5744399,3348636,65716666,3276302,11797066,68600408,60129642,-60201976,200567,3707650,18806742,27674144,1106654,28482880,30665479,10708062,15098560,6871970,1360808.0,20990.0,15702632.0,11328947.0,754515.0,23059.0,9636611.0,-1713326.0,1570514.0,20990.0,1508893.0,-4162352.0,1483574.0,-211333.0,2991335,en-US,US,EQUITY,True,Delayed Quote,USD,False,False,0,8.3524,4.1762,2.0 - 16.255,-5.9025993,-0.36312518,2.0,16.255,1620849600,1636405200,1637010000,0.023183038,10.24 - 10.3524,10.35,10.35,10.44,10,11,finmb_558073021,NasdaqCM,Greenbrook TMS Inc.,USD,5300,2966,11.173833,-0.82143307,-0.07351399,12.130369,-1.7779694,-0.14657174,166560800,15,America/New_York,EDT,-14400000,2,NCM,POST,us_market,Greenbrook TMS Inc.,10.3524,1630526399,0.0023994446,10.37,10.3524,10.24,1200,0.97,,,16.25,2.0,11.17,12.13,5.3k,2.97k,16.09M,,7M,33.60%,18.62%,11.63k,4.8,,0.08%,6.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-77.01%,-47.69%,-23.27%,-411.21%,43.02M,3.19,-0.90%,11.59M,-21.05M,-33.13M,,,5.93M,0.43,44.18M,,0.89,,-11.64M,-2.06M,Value,M4W 3P4,Healthcare,366,"Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.",Toronto,416 621 4642,ON,1609372800,Canada,http://www.greenbrooktms.com,86400,890 Yonge Street,Medical Care Facilities,7th Floor
t-2,GBNH,2273062,16089100,,,-7667755,-70378,-7636132,5188069,3962853,-2922947,-2922947,,-708665,,,,0,12006570,14929517,8043717,-4744808,,-7667755,-7636132,5860233,3213160,49042749,11840945,10513909,60813316,60340975,-51713190,99281,3707650,9170131,25657532,1757301,27953157,23292276,12216955,1239045,5317023,-144336.0,20990.0,-1862023.0,-1863771.0,158622.0,23059.0,-4424143.0,-2560372.0,1526675.0,20990.0,-1349442.0,610622.0,4884241.0,-612370.0,-2365256,en-US,US,EQUITY,True,Delayed Quote,USD,False,False,0,8.3524,4.1762,2.0 - 16.255,-5.9025993,-0.36312518,2.0,16.255,1620849600,1636405200,1637010000,0.023183038,10.24 - 10.3524,10.35,10.35,10.44,10,11,finmb_558073021,NasdaqCM,Greenbrook TMS Inc.,USD,5300,2966,11.173833,-0.82143307,-0.07351399,12.130369,-1.7779694,-0.14657174,166560800,15,America/New_York,EDT,-14400000,2,NCM,POST,us_market,Greenbrook TMS Inc.,10.3524,1630526399,0.0023994446,10.37,10.3524,10.24,1200,0.97,,,16.25,2.0,11.17,12.13,5.3k,2.97k,16.09M,,7M,33.60%,18.62%,11.63k,4.8,,0.08%,6.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-77.01%,-47.69%,-23.27%,-411.21%,43.02M,3.19,-0.90%,11.59M,-21.05M,-33.13M,,,5.93M,0.43,44.18M,,0.89,,-11.64M,-2.06M,Value,M4W 3P4,Healthcare,366,"Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.",Toronto,416 621 4642,ON,1609372800,Canada,http://www.greenbrooktms.com,86400,890 Yonge Street,Medical Care Facilities,7th Floor
t-3,GBNH,9624054,16089100,,,-9734642,-38755,-9477505,4362732,2299062,-3791512,-3791512,,-694208,,,,0,9788555,13580067,7489493,-5943130,,-9734642,-9477505,5976065,3042104,46239175,19307769,6466406,65508189,60342723,-44077058,142792,3707650,13594274,21309121,1391125,29298875,26525599,10867513,1558719,6432363,952334.0,20990.0,1344756.0,11501723.0,-97752.0,10767589.0,10381598.0,-1120125.0,1552396.0,20990.0,88962.0,-610622.0,5861439.0,-612370.0,5216478,en-US,US,EQUITY,True,Delayed Quote,USD,False,False,0,8.3524,4.1762,2.0 - 16.255,-5.9025993,-0.36312518,2.0,16.255,1620849600,1636405200,1637010000,0.023183038,10.24 - 10.3524,10.35,10.35,10.44,10,11,finmb_558073021,NasdaqCM,Greenbrook TMS Inc.,USD,5300,2966,11.173833,-0.82143307,-0.07351399,12.130369,-1.7779694,-0.14657174,166560800,15,America/New_York,EDT,-14400000,2,NCM,POST,us_market,Greenbrook TMS Inc.,10.3524,1630526399,0.0023994446,10.37,10.3524,10.24,1200,0.97,,,16.25,2.0,11.17,12.13,5.3k,2.97k,16.09M,,7M,33.60%,18.62%,11.63k,4.8,,0.08%,6.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-77.01%,-47.69%,-23.27%,-411.21%,43.02M,3.19,-0.90%,11.59M,-21.05M,-33.13M,,,5.93M,0.43,44.18M,,0.89,,-11.64M,-2.06M,Value,M4W 3P4,Healthcare,366,"Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.",Toronto,416 621 4642,ON,1609372800,Canada,http://www.greenbrooktms.com,86400,890 Yonge Street,Medical Care Facilities,7th Floor
